SeekIn Cancer Recurrence Monitoring Kit Gains CE-IVD Mark

SeekIn received the CE-IVD mark for its SeekInCure cancer recurrence monitoring kit, which tests for minimal residual disease (MRD) — an indicator of possible recurrence.

The test looks for cancer genome alterations in cell-free DNA — degraded DNA tumor cell fragments that are released into the bloodstream — and identifies patients who are more likely to relapse as well as lower-risk patients who can then avoid unnecessary follow-up treatment.

The test can be performed within a month of radical surgery, a procedure in which a tumor and a large amount of tissue are removed.